Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to <scp>HIV</scp> virological suppression
Teresa Aldámiz‐Echevarria(Instituto de Salud Carlos III), CoRIS Cohort, Meritxell Gavalda Manso(Hospital Universitario Son Espases), María del Mar Arcos-Rueda(Hospital Universitario La Paz), Marta Rava(Instituto de Salud Carlos III), Laura Pérez‐Martínez(Hospital San Pedro), María José Núñez Orantos(Instituto de Salud Carlos III), Mar Masiá(Universidad de Alcalá), María Remedios Alemán Valls, José María Bellón(Hospital General Universitario Gregorio Marañón), Cristina Hernández Gutiérrez(Hospital Universitario Príncipe de Asturias), Leire Pérez(Instituto de Salud Carlos III), Ines Suarez-García(Instituto de Salud Carlos III), V Asensi(Hospital Universitario Central de Asturias), Joaquim Peraire(Instituto de Salud Carlos III), Marian Fernandez Lopez(Hospital Universitario Virgen de la Arrixaca), JA Iribarren(Biogipuzkoa Health Research Institute), María Tasias Pitarch(Hospital Universitari i Politècnic La Fe), Diana Corona-Mata(Instituto de Salud Carlos III), Alfonso Cabello-Úbeda(Hospital Universitario Fundación Jiménez Díaz), Lucio García-Fraile(Instituto de Salud Carlos III), Marta Montero‐Alonso(Instituto de Investigación Sanitaria La Fe), Santiago Moreno Guillen(Universidad de Alcalá), Francisco Tejerina(Hospital General Universitario Gregorio Marañón), Arkaitz Imaz(Bellvitge University Hospital), Cristina Diez(Instituto de Salud Carlos III), Ángela Gutiérrez Liarte(Hospital Universitario de La Princesa), Núria Espinosa, Irene Portilla‐Tamarit(University of Alicante), Chiara Fanciulli
Cited by 1
Related Papers
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|Clinical Microbiology and Infection|2020|128
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
|Clinical Cancer Research|2016|104